Deltex Medical 2018 Results

Deltex Medical Group plc (AIM: DEMG), the global leader in oesophageal Doppler monitoring, has announced its audited results for the year ended 31 December 2018.

Find the link to the London Stock Exchange page here.

From the announcement, Deltex Chairman Nigel Keen stated:

“I am delighted to see the profitability and cash generation in the fourth quarter of 2018, which helps to validate Deltex Medical’s new strategy.

“The Group continued to generate cash in the first quarter of 2019.”

“The focus on patient safety, from both regulators and patient advocacy groups, is increasing which is helping to create interest in Deltex Medical’s TrueVue System.”